Global health problems can be solved by finding common ground between the needs of patients in poor countries and the pragmatic needs of companies
BIO Ventures for Global Health (BVGH) is a non-profit organization whose mission is to save lives by accelerating the development of novel drugs, vaccines, and diagnostics coming from the biotechnology industry that address the unmet medical needs of the developing world.
Finding the Common Ground
BVGH focuses on the two main barriers to biotech involvement in global health: the financial realities that keep many innovator companies from focusing on neglected diseases with low market potential, and the lack of information about how they can apply their expertise and technologies to global health.
BVGH develops financial incentives to engage biopharmaceutical companies in global health research and development and delivers information to drive action.
BIO Ventures for Global Health History
BIO Ventures for Global Health was founded in 2004 with a start-up grant from the Bill & Melinda Gates Foundation, and the support of the Biotechnology Industry Association (BIO) and the Rockefeller Foundation. BVGH currently receives funding from the Bill & Melinda Gates Foundation and other companies and individuals.